The Readout Loud cover image

384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen

The Readout Loud

00:00

Recent Acero purchase and liver disease focus

Mike details the Acero acquisition for severe fatty liver (F4 MASH) and its strategic fit.

Play episode from 17:46
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app